Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
NAD(P)H:quinone acceptor oxidoreductase-1 (NQO1) is a ubiquitous flavin adenine dinucleotide-dependent flavoprotein that promotes obligatory two-electron reductions of quinones, quinonimines, nitroaromatics, and azo dyes. NQO1 is a multifunctional antioxidant enzyme whose expression and deletion are...
Saved in:
Main Authors: | Bhargav Shreevatsa, Chandan Dharmashekara, Vikas Halasumane Swamy, Meghana V. Gowda, Raghu Ram Achar, Vivek Hamse Kameshwar, Rajesh Kumar Thimmulappa, Asad Syed, Abdallah M. Elgorban, Salim S. Al-Rejaie, Joaquín Ortega-Castro, Juan Frau, Norma Flores-Holguín, Chandan Shivamallu, Shiva Prasad Kollur, Daniel Glossman-Mitnik |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f039d1eae82d4a3b8bc5c8c39db5e75f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
4NQO Carcinogenesis: A Model of Oral Squamous Cell Carcinoma
by: Rivera Martínez,César Andrés
Published: (2012) -
NQO1 Enzyme and its Role in Cellular Protection; an Insight
by: Ahmed Atia, et al.
Published: (2020) -
Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population
by: Imen Hemissi, et al.
Published: (2021) -
Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence
by: Huan Liu, et al.
Published: (2021) -
Characteristics of social media ‘detoxification’ in university students
by: Joseph El-Khoury, et al.
Published: (2021)